695 related articles for article (PubMed ID: 8389648)
1. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
[TBL] [Abstract][Full Text] [Related]
2. Morphine reduces the release of met-enkephalin-like material from the rat spinal cord in vivo by acting at delta opioid receptors.
Collin E; Mauborgne A; Bourgoin S; Benoliel JJ; Hamon M; Cesselin F
Neuropeptides; 1994 Jul; 27(1):75-83. PubMed ID: 7969822
[TBL] [Abstract][Full Text] [Related]
3. Kappa-/mu-receptor interactions in the opioid control of the in vivo release of substance P-like material from the rat spinal cord.
Collin E; Mauborgne A; Bourgoin S; Mantelet S; Ferhat L; Hamon M; Cesselin F
Neuroscience; 1992 Nov; 51(2):347-55. PubMed ID: 1281527
[TBL] [Abstract][Full Text] [Related]
4. Mu and delta opioid receptors mediate opposite modulations by morphine of the spinal release of cholecystokinin-like material.
Benoliel JJ; Collin E; Mauborgne A; Bourgoin S; Legrand JC; Hamon M; Cesselin F
Brain Res; 1994 Aug; 653(1-2):81-91. PubMed ID: 7982079
[TBL] [Abstract][Full Text] [Related]
5. Kappa-opioid receptor stimulation abolishes mu- but not delta-mediated inhibitory control of spinal Met-enkephalin release.
Collin E; Bourgoin S; Ferhat L; Hamon M; Cesselin F
Neurosci Lett; 1992 Jan; 134(2):238-42. PubMed ID: 1317026
[TBL] [Abstract][Full Text] [Related]
6. Altered opioid-mediated control of the spinal release of dynorphin and met-enkephalin in polyarthritic rats.
Ballet S; Mauborgne A; Hamon M; Cesselin F; Collin E
Synapse; 2000 Sep; 37(4):262-72. PubMed ID: 10891863
[TBL] [Abstract][Full Text] [Related]
7. Feedback inhibition of met-enkephalin release from the rat spinal cord in vivo.
Collin E; Bourgoin S; Mantelet S; Hamon M; Cesselin F
Synapse; 1992 May; 11(1):76-84. PubMed ID: 1604425
[TBL] [Abstract][Full Text] [Related]
8. Increased in vivo release of calcitonin gene-related peptide-like material from the spinal cord in arthritic rats.
Collin E; Mantelet S; Frechilla D; Pohl M; Bourgoin S; Hamon M; Cesselin F
Pain; 1993 Aug; 54(2):203-211. PubMed ID: 8233535
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibitory/stimulatory modulation of spinal CCK release by mu and delta opioid agonists, and selective blockade of mu-dependent inhibition by kappa receptor stimulation.
Benoliel JJ; Bourgoin S; Mauborgne A; Legrand JC; Hamon M; Cesselin F
Neurosci Lett; 1991 Apr; 124(2):204-7. PubMed ID: 1648690
[TBL] [Abstract][Full Text] [Related]
10. Polyarthritis-associated changes in the opioid control of spinal CGRP release in the rat.
Ballet S; Mauborgne A; Benoliel JJ; Bourgoin S; Hamon M; Cesselin F; Collin E
Brain Res; 1998 Jun; 796(1-2):198-208. PubMed ID: 9689470
[TBL] [Abstract][Full Text] [Related]
11. Opioidergic inhibition of capsaicin-evoked release of glutamate from rat spinal dorsal horn slices.
Ueda M; Sugimoto K; Oyama T; Kuraishi Y; Satoh M
Neuropharmacology; 1995 Mar; 34(3):303-8. PubMed ID: 7630485
[TBL] [Abstract][Full Text] [Related]
12. Opioid control of the release of Met-enkephalin-like material from the rat spinal cord.
Bourgoin S; Collin E; Benoliel JJ; Chantrel D; Mauborgne A; Pohl M; Hamon M; Cesselin F
Brain Res; 1991 Jun; 551(1-2):178-84. PubMed ID: 1655159
[TBL] [Abstract][Full Text] [Related]
13. Opposite effects of delta and mu opioid receptor agonists on the in vitro release of substance P-like material from the rat spinal cord.
Mauborgne A; Lutz O; Legrand JC; Hamon M; Cesselin F
J Neurochem; 1987 Feb; 48(2):529-37. PubMed ID: 2432185
[TBL] [Abstract][Full Text] [Related]
14. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
15. In vivo tonic inhibition of spinal substance P (-like material) release by endogenous opioid(s) acting at delta receptors.
Collin E; Mauborgne A; Bourgoin S; Chantrel D; Hamon M; Cesselin F
Neuroscience; 1991; 44(3):725-31. PubMed ID: 1721687
[TBL] [Abstract][Full Text] [Related]
16. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
Fox DA; Burks TF
J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
[TBL] [Abstract][Full Text] [Related]
17. Gastric effects of mu-, delta- and kappa-opioid receptor agonists on brainstem unitary responses in the neonatal rat.
Yuan CS
Eur J Pharmacol; 1996 Oct; 314(1-2):27-32. PubMed ID: 8957215
[TBL] [Abstract][Full Text] [Related]
18. Opioid modulation of capsaicin-evoked release of substance P from rat spinal cord in vivo.
Aimone LD; Yaksh TL
Peptides; 1989; 10(6):1127-31. PubMed ID: 2482963
[TBL] [Abstract][Full Text] [Related]
19. Spinal mu and delta, but not kappa, opioid-receptor agonists attenuate responses to noxious colorectal distension in the rat.
Danzebrink RM; Green SA; Gebhart GF
Pain; 1995 Oct; 63(1):39-47. PubMed ID: 8577489
[TBL] [Abstract][Full Text] [Related]
20. Gastric effects of methylnaltrexone on mu, kappa, and delta opioid agonists induced brainstem unitary responses.
Yuan CS; Foss JF
Neuropharmacology; 1999 Mar; 38(3):425-32. PubMed ID: 10219980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
